James Investment Research »

Catalyst Pharmaceutical Partners shares owned by James Investment Research

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by James Investment Research from 13F filings

Historical chart of James Investment Research investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by James Investment Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by James Investment Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $785k 34k 23.34

More positions owned by James Investment Research

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Gold Tr Ishares New (IAU)
Enova Intl (ENVA)
JPMorgan Chase & Co. (JPM)
Wal-Mart Stores (WMT)
Caterpillar (CAT)
NOVA MEASURING Instruments L (NVMI)
Broadcom (AVGO)
Amazon (AMZN)
Goldman Sachs (GS)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)

View all positions for James Investment Research

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Fundsmith
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
Renaissance Technologies
Royce & Associates
Arrowstreet Capital, Limited Partnership
Millennium Management
Charles Schwab Investment Management
Invesco
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners